Fountain Biopharma Inc.
Records under this name other than patents Fountain Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Fountain Biopharma Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,758,580 | Uses of antibodies to interleukin-6 in cancer treatment Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,370,443 | Method of treating autoimmune disease by administering antibodies to interleukin-6 Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,234,035 | Antibodies to interleukin-6 Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,540,673 | Methods for producing recombinant glycoproteins with modified glycosylation Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,745,729 | Methods for producing recombinant glycoproteins with modified glycosylation Formerly held In force · USPTO record | In force | USPTO record |